Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000584 |
Amiloride |
Amiloride inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 9930755
|
D000584 |
Amiloride |
Amiloride inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 11897840
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CACNA1H mRNA | affects expression | 16483693
|
D001464 |
Barium |
CACNA1H mRNA alternative form results in increased transport of Barium | increases transport | 11179973
|
C055494 |
caffeic acid phenethyl ester |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CACNA1H mRNA | affects cotreatment|decreases expression | 20360939
|
D002118 |
Calcium |
Amiloride inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 9930755
|
D002118 |
Calcium |
CACNA1H protein results in increased transport of Calcium | increases transport | 9930755
|
D002118 |
Calcium |
Mibefradil inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 9930755
|
D002118 |
Calcium |
Nickel inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 9930755
|
D002118 |
Calcium |
Amiloride inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 11897840
|
D002118 |
Calcium |
CACNA1H protein results in increased transport of Calcium | increases transport | 11897840
|
D002118 |
Calcium |
Nickel inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 11897840
|
D002118 |
Calcium |
CACNA1H protein results in increased transport of Calcium | increases transport | 11073957
|
D003609 |
Dactinomycin |
Dactinomycin inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] | decreases reaction|increases expression | 19292980
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CACNA1H mRNA | affects cotreatment|decreases expression | 20360939
|
D005576 |
Forskolin |
Mibefradil inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D005576 |
Forskolin |
Nickel inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
C020754 |
herbimycin |
herbimycin results in increased activity of CACNA1H protein | increases activity | 18309285
|
D015056 |
1-Methyl-3-isobutylxanthine |
Mibefradil inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D015056 |
1-Methyl-3-isobutylxanthine |
Nickel inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D020748 |
Mibefradil |
Mibefradil inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 9930755
|
D020748 |
Mibefradil |
Mibefradil inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
D009532 |
Nickel |
Nickel inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 9930755
|
D009532 |
Nickel |
Nickel inhibits the reaction [CACNA1H protein results in increased transport of Calcium] | decreases reaction|increases transport | 11897840
|
D009532 |
Nickel |
Nickel inhibits the reaction [[Forskolin co-treated with 1-Methyl-3-isobutylxanthine] results in increased activity of CACNA1H protein] | affects cotreatment|decreases reaction|increases activity | 17110049
|
C029341 |
oxophenylarsine |
oxophenylarsine results in decreased activity of CACNA1H protein | decreases activity | 18309285
|
C093973 |
PD 98059 |
PD 98059 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA] | decreases expression|decreases reaction | 19292980
|
C093642 |
SB 203580 |
SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA] | decreases expression|decreases reaction | 19292980
|
C084178 |
telmisartan |
PD 98059 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA] | decreases expression|decreases reaction | 19292980
|
C084178 |
telmisartan |
SB 203580 inhibits the reaction [telmisartan results in decreased expression of CACNA1H mRNA] | decreases expression|decreases reaction | 19292980
|
C084178 |
telmisartan |
telmisartan inhibits the reaction [AGT protein results in increased expression of CACNA1H mRNA] | decreases reaction|increases expression | 19292980
|
C084178 |
telmisartan |
telmisartan results in decreased expression of CACNA1H mRNA | decreases expression | 19292980
|
C060152 |
tyrphostin 47 |
tyrphostin 47 results in increased activity of CACNA1H protein | increases activity | 18309285
|
D015032 |
Zinc |
Zinc results in decreased activity of CACNA1H protein | decreases activity | 16410023
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.52 | 18287403 |
MESH:D000169 |
Acrodermatitis |
|
Zinc |
5.37 | 17190629 16889938 17202136 |
MESH:D055371 |
Acute Lung Injury |
|
Nickel |
4.54 | 16166738 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.82 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.86 | 17620307 19061943 17162532 16434500 18056438 19052882 |
MESH:D000544 |
Alzheimer Disease |
|
Zinc |
2.75 | 17119284 16325427 16410023 16580781 |
MESH:D000755 |
Anemia, Sickle Cell |
|
Zinc |
4.86 | 16916123 |
MESH:D001249 |
Asthma |
|
Zinc |
2.94 | 17085522 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 16754686 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Dactinomycin |
5.51 | 14601052 |
MESH:D001930 |
Brain Injuries |
|
Zinc |
4.65 | 17109824 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.55 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Nickel |
2.55 | 15986119 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
1.84 | 17428255 19701751 16681979 18506893 18691550 16698587 19394651 19539802 18056438 17055752 20432363 18788625 18494052 19171122 19519916 20514400 19383236 17138121 19107877 16569478 20101231 16540662 20524982 16935385 17162532 18978308 20007298 16878318 16807293 19208518 20935162 16502159 20512989 19919837 19418558 16328049 11831363 20727157 10737359 10672840 18665156 20214788 18785209 17978847 18971187 16830150 20084675 18393292 16779866 19335982 21159647 3581430 19052882 18210153 19822196 3084413 17173139 16288022 17761372 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Zinc |
2.89 | 16543248 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Amiloride |
5.04 | 14644129 |
MESH:D002318 |
Cardiovascular Diseases |
|
Zinc |
3.63 | 16936243 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.83 | 21159647 2727394 7505956 17174075 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.65 | 19052882 |
MESH:D003092 |
Colitis |
|
Amiloride |
5.07 | 12065299 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Zinc |
2.43 | 19302082 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Nickel |
3.91 | 19470301 17100760 17244072 |
MESH:D003877 |
Dermatitis, Contact |
|
Nickel |
4.59 | 2952479 |
MESH:D003920 |
Diabetes Mellitus |
|
Zinc |
4.16 | 16479319 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.18 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
2.05 | 19107877 |
MESH:D004832 |
Epilepsy, Absence |
marker/mechanism |
|
| |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.09 | 16302075 |
MESH:D004938 |
Esophageal Neoplasms |
|
Zinc |
2.85 | 16543248 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.15 | 21071580 20387270 |
MESH:D005756 |
Gastritis |
|
Zinc |
4.77 | 17241300 |
MESH:D006130 |
Growth Disorders |
|
Amiloride |
8.93 | 19703807 |
MESH:D006130 |
Growth Disorders |
|
Zinc |
8.93 | 17217573 |
MESH:D006333 |
Heart Failure |
|
Zinc |
3.58 | 17162251 |
MESH:D006335 |
Heart Injuries |
|
Zinc |
5.74 | 17074742 |
MESH:D016481 |
Helicobacter Infections |
|
Zinc |
4.49 | 17241300 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Zinc |
4.65 | 17276780 |
MESH:D015658 |
HIV Infections |
|
Nickel |
3.79 | 17263646 |
MESH:D006973 |
Hypertension |
|
Amiloride |
6.49 | 18524855 19344079 15174897 |
MESH:D006973 |
Hypertension |
|
telmisartan |
6.49 | 16077267 |
MESH:D020514 |
Hypokalemic Periodic Paralysis |
|
Amiloride |
5.81 | 19822448 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.41 | 18306037 |
MESH:D007249 |
Inflammation |
|
Amiloride |
8.55 | 17237260 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.55 | 18785209 |
MESH:D007249 |
Inflammation |
|
Nickel |
8.55 | 16166738 |
MESH:D007414 |
Intestinal Neoplasms |
|
caffeic acid phenethyl ester |
4.55 | 10783313 |
MESH:D007511 |
Ischemia |
|
Zinc |
4.59 | 16584753 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.41 | 18306037 |
MESH:D007674 |
Kidney Diseases |
|
caffeic acid phenethyl ester |
6.57 | 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Zinc |
6.57 | 16960431 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Zinc |
4.38 | 16518626 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.02 | 16316344 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
PD 98059 |
5.19 | 16972261 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
caffeic acid phenethyl ester |
3.96 | 16766008 |
MESH:D056929 |
Liddle Syndrome |
|
Amiloride |
5.93 | 19344079 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.80 | 19638242 18407596 18522880 20032147 18665156 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.09 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.22 | 19255062 9163691 19294768 19427195 21167192 20405173 20101389 15885732 21278145 10737359 20583210 20492335 21071580 18978307 19254457 20118626 19638242 20501860 12112319 16942905 19996281 19551842 19426721 19850985 18648771 20434301 15175105 19090486 19642983 19256749 2862719 2422723 19690152 19812893 18977376 20137499 19499222 18644402 20452335 12771043 19833225 19073162 18754104 21047994 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.60 | 19519916 3124819 9362446 18775883 18308698 18093689 19009564 18544905 19539802 18079962 18282651 17942915 16267830 18253720 16842330 19004024 18164116 19126423 21159647 17174075 2563599 17854601 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.76 | 6695378 20970405 21163286 20512841 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Zinc |
3.27 | 12773700 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Amiloride |
5.26 | 14644129 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.55 | 3581430 9029167 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.30 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.09 | 20387270 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.75 | 17882678 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.41 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.51 | 2563599 |
MESH:D011225 |
Pre-Eclampsia |
|
Zinc |
4.14 | 17114810 |
MESH:D011471 |
Prostatic Neoplasms |
|
Zinc |
3.84 | 12429649 16606632 16700911 16517595 |
MESH:D011507 |
Proteinuria |
|
telmisartan |
5.56 | 16077267 |
MESH:D012162 |
Retinal Degeneration |
|
Zinc |
4.09 | 16584753 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Dactinomycin |
5.04 | 14601052 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.95 | 7505956 |
MESH:D014062 |
Tongue Neoplasms |
|
Zinc |
4.36 | 16543248 |